Immersive, Open-World Virtual Reality for Dementia Care: NeuroVRX Pilot Study
Abstract
1. Introduction
1.1. Background and Motivation
1.2. Research Objective
2. Methods
2.1. Research Design
2.2. Participants
2.3. System and Application Design
2.4. Outcome Measures
3. Results
3.1. Participant and Session Characteristics
3.2. Session Results
3.3. Session Reports
3.3.1. Session Report: Participant A
3.3.2. Session Report: Participant B
3.3.3. Session Report: Participant C
3.4. Application Mechanics and User Experience
3.5. Changes in Mood
3.6. Cyber Sickness and Physical Effects
4. Discussion
4.1. Interpretation of Results
4.2. Limitations
4.3. Practical Implications
5. Conclusions
5.1. Summary of Key Findings
5.2. Comparison to Prior Work
5.3. Future Outlook
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
Abbreviations
| 3D | Three-dimensional |
| ADRD | Alzheimer’s disease and related dementias |
| BMI | Body mass index |
| CST | Cognitive Stimulation Therapy |
| CSQ | Cyber Sickness Questionnaire |
| CSQ-VR | Cyber Sickness Questionnaire (VR) |
| GBD | Global Burden of Disease |
| GDPR | General Data Protection Regulation |
| NeuroVRX | Neurocognitive virtual reality exploration |
| POMS | Profile of Mood States |
| PwD | People with dementia |
| VR | Virtual reality |
| VRNQ | Virtual Reality Neuroscience Questionnaire |
| VRNQ-DE | Virtual Reality Neuroscience Questionnaire, German version |
| WHO | World Health Organization |
| Wi-Fi | Wireless local area network |
Appendix A
| Item | Model / Configuration | Manufacturer |
|---|---|---|
| HMD | Meta Quest 3 (128 GB) | Meta Platforms, Inc. (Menlo Park, CA, USA) |
| Controllers | Meta 3 Touch Plus; gesture and hand tracking off | Meta Platforms, Inc. (Menlo Park, CA, USA) |
| Host Machine | MSI Titan 18 HX A14VIG; Intel(R) Core(TM) i9-14900HX 2.20 GHz; 128 GB RAM; RTX 4090 Laptop GPU; 32 GB RAM | Micro-Star International Co., Ltd. (MSI) (Zhonghe District, New Taipei City, Taiwan) |
| OS & Drivers | Windows 11 Pro 24H2 (26,100.3476); NVIDIA 31.0.15.5222 (11 April 2024) | Microsoft Corporation (Redmond, WA, USA); NVIDIA Corporation (Santa Clara, CA, USA) |
| Audio I/O | HMD integrated speakers; system volume 75% | — |
| Link | Wi-Fi 5 GHz: 1300 Mbps (802.11ac), WPA2, dedicated SSID |
| Router/AP | TP-Link (Shenzhen, Guangdong, China) Archer C7 AC1750 v2, FW: Archer C7(EU) V2 241108 |
| Codec/Transport | Virtual Desktop; 120 FPS; HEVC; SSW Enabled; Snapdragon Game Super Resolution; Video Buffering |
| Component | Software | Version/ Notes | Developer/Publisher |
|---|---|---|---|
| Application | The Elder Scrolls V: Skyrim VR | 1.4.15 | Bethesda Softworks LLC (Rockville, MD, USA) |
| Mad God Overhaul | 2.6 | by Moyse06 (https://www.nexusmods.com/skyrimspecialedition/mods/107780, accessed on 27 November 2025) | |
| Mod Organizer 2 | 2.5.0 | Mod Organizer 2 Team (https://github.com/ModOrganizer2, accessed on 27 November 2025) | |
| VR runtime | Steam | build 1747701111 | Valve Corporation (Bellevue, WA, USA) |
| SteamVR | 2.11.2 | Valve Corporation (Bellevue, WA, USA) | |
| Virtual Desktop | 1.34.8-72 | Virtual Desktop, Inc.; (Los Angeles, CA, USA) | |
| Natural Locomotion | build 15890947 (Oct 2024) | myousoftware (https://store.steampowered.com/publisher/myou, accessed on 27 November 2025) |
| Variable | Description |
|---|---|
| Subject | Identifier for each participant |
| Gender | Gender of the participant |
| Age of Subject | Age of the participant at the time of the study |
| Age of Diagnosis | Age at which the participant received their diagnosis |
| Prone to Motion Sickness | Whether the participant is prone to motion sickness |
| Gaming Experience | Level of previous gaming experience |
| VR Experience | Level of previous virtual reality experience |
| Session Scenario | Name of the VR session scenario |
| Session Duration (minutes) | Duration of the VR session |
| Session Distance (km) | Distance covered during the VR session |
| Session Steps | Number of steps performed during the VR session |
| Recommendation | If a participant would recommend the experience |
| ASTS-pre and ASTS-post [29] | Profile of Mood States (German POMS) |
| Sadness | Sadness score |
| Hopelessness | Hopelessness score |
| Fatigue | Fatigue score |
| Positive Mood | Positive mood score |
| VRNQ-DE [31] | VR Neuropsychological Questionnaire (German) |
| User Experience | User experience score |
| Gameplay Mechanics | Gameplay mechanics score |
| CSQ [30] | Measures of cybersickness (German) |
| Nausea | Nausea score |
| Balance | Balance disturbance score |
| Eye Strain | Eye strain score |
| Participant A | Participant B | Participant C | ||
|---|---|---|---|---|
| ASTS-pre | ||||
| Sadness | 3 | 3 | 3 | 3.00 |
| Hopelessness | 3 | 3 | 4 | 3.33 |
| Fatigue | 4 | 8 | 4 | 5.33 |
| Positive Mood | 21 | 12 | 26 | 19.67 |
| ASTS-post | ||||
| Sadness | 3 | 3 | 3 | 3.00 |
| Hopelessness | 3 | 3 | 3 | 3.00 |
| Fatigue | 4 | 7 | 13 | 8.00 |
| Positive Mood | 24 | 12 | 17 | 17.67 |
| Cyber Sickness | Participant A | Participant B | Participant C | |
|---|---|---|---|---|
| Nausea | 2 | 2 | 2 | 2 |
| Balance | 2 | 2 | 2 | 2 |
| Eye Strain | 2 | 2 | 2 | 2 |
| Total | 6 | 6 | 6 | 6 |
References
- Wimo, A.; Seeher, K.; Cataldi, R.; Cyhlarova, E.; Dielemann, J.L.; Frisell, O.; Guerchet, M.; Jönsson, L.; Malaha, A.K.; Nichols, E.; et al. The worldwide costs of dementia in 2019. Alzheimer’s Dement. J. Alzheimer’s Assoc. 2023, 19, 2865–2873. [Google Scholar] [CrossRef]
- Zhong, S.; Xiao, C.; Li, R.; Lan, Y.; Gong, C.; Feng, C.; Qi, H.; Lin, Y.; Qin, C. The global, regional, and national burdens of dementia in 204 countries and territories from 1990 to 2021: A trend analysis based on the Global Burden of Disease Study 2021. Medicine 2025, 104, e41836. [Google Scholar] [CrossRef]
- Zhang, X.; Guo, T.; Zhang, Y.; Jiao, M.; Ji, L.; Dong, Z.; Li, H.; Chen, S.; Zheng, W.; Jing, Q. Global burden of Alzheimer’s disease and other dementias attributed to metabolic risks from 1990 to 2021: Results from the global burden of disease study 2021. BMC Psychiatry 2024, 24, 910. [Google Scholar] [CrossRef] [PubMed]
- Institute for Health Metrics and Evaluation (IHME). Global Burden of Disease Study 2021 (GBD 2021) Data; IHME: Seattle, WA, USA, 2021. [Google Scholar]
- World Health Organization. Global Status Report on the Public Health Response to Dementia, 1st ed.; World Health Organization: Geneva, Switzerland, 2021. [Google Scholar]
- Kjeldsen, E.W.; Frikke-Schmidt, R. Causal cardiovascular risk factors for dementia: Insights from observational and genetic studies. Cardiovasc. Res. 2025, 121, 537–549. [Google Scholar] [CrossRef]
- Hao, N.; Bai, X.; Hu, A.; Zhao, G.; Chen, Y.; Zhao, J.; Ling, Q.; Li, X.; Cai, C.; Wang, Q.; et al. Assessing the Global, Regional, and National Impact of High Body Mass Index on Alzheimer’s Disease and Other Dementias Between 1990 and 2019. J. Alzheimer’s Dis. JAD 2024, 97, 293–307. [Google Scholar] [CrossRef] [PubMed]
- Mobaderi, T.; Kazemnejad, A.; Salehi, M. Exploring the impacts of risk factors on mortality patterns of global Alzheimer’s disease and related dementias from 1990 to 2021. Sci. Rep. 2024, 14, 15583. [Google Scholar] [CrossRef]
- Mukadam, N.; Wolters, F.J.; Walsh, S.; Wallace, L.; Brayne, C.; Matthews, F.E.; Sacuiu, S.; Skoog, I.; Seshadri, S.; Beiser, A.; et al. Changes in prevalence and incidence of dementia and risk factors for dementia: An analysis from cohort studies. Lancet Public Health 2024, 9, e443–e460. [Google Scholar] [CrossRef] [PubMed]
- Rai, H.; Yates, L.; Orrell, M. Cognitive Stimulation Therapy for Dementia. Clin. Geriatr. Med. 2018, 34, 653–665. [Google Scholar] [CrossRef]
- Woods, B.; Rai, H.K.; Elliott, E.; Aguirre, E.; Orrell, M.; Spector, A. Cognitive stimulation to improve cognitive functioning in people with dementia. Cochrane Database Syst. Rev. 2023, 2023, CD005562. [Google Scholar] [CrossRef]
- Chang, C.H.; Huang, K.Y.; Kuo, L.H.; Cheng, Y.W.; Huang, S.F.; Chuang, T.H.; Huang, C.M.; Guo, J.L. Pilot Randomized Controlled Study on the Effectiveness of a Virtual Reality-Based Dementia Prevention Program Using Self-Regulated Learning Strategies Among Older Adults with Mild Cognitive Impairment. Healthcare 2025, 13, 1082. [Google Scholar] [CrossRef]
- Navarro-Ramos, C.D.; Murataya-Gutiérrez, J.; Acosta-Quiroz, C.O.; García-Flores, R.; Echeverría-Castro, S.B. Effects of Cognitive Training with Virtual Reality in Older Adults: A Systematic Review. Brain Sci. 2025, 15, 910. [Google Scholar] [CrossRef]
- Jeong, H.; Kang, D.; Kim, J.E.; Lim, J.; Lee, H.W. Preliminary study on the feasibility of virtual reality-based cognitive training on patients with mild to moderate Alzheimer’s disease. J. Alzheimer’s Dis. Rep. 2025, 9, 25424823251385901. [Google Scholar] [CrossRef] [PubMed]
- Yu, J.; Song, J.; Shen, Q. Effects of fully immersive virtual reality training on cognitive function in patients with mild cognitive impairment: A systematic review and meta-analysis. Front. Hum. Neurosci. 2024, 18, 1467697. [Google Scholar] [CrossRef]
- Poli, F.; Meyer, M.; Mars, R.B.; Hunnius, S. Exploration in 4-year-old children is guided by learning progress and novelty. Child Dev. 2025, 96, 192–202. [Google Scholar] [CrossRef]
- Kakade, S.; Dayan, P. Dopamine: Generalization and bonuses. Neural Netw. 2002, 15, 549–559. [Google Scholar] [CrossRef] [PubMed]
- Liu, Z.X.; Shen, K.; Olsen, R.K.; Ryan, J.D. Visual Sampling Predicts Hippocampal Activity. J. Neurosci. Off. J. Soc. Neurosci. 2017, 37, 599–609. [Google Scholar] [CrossRef] [PubMed]
- Banerjee, S. Systematic Literature Review of Wandering Prevention Technologies for Dementia Care. J. Technol. Hum. Serv. 2025, 43, 234–245. [Google Scholar] [CrossRef]
- Agrawal, A.K.; Gowda, M.; Achary, U.; Gowda, G.S.; Harbishettar, V. Approach to Management of Wandering in Dementia: Ethical and Legal Issue. Indian J. Psychol. Med. 2021, 43, S53–S59. [Google Scholar] [CrossRef]
- Brookman, R.; Shatnawi, E.; Lukic, K.; Sirota, S.; Harris, C.B. Dementia-related stigma across age groups and perspectives: Similarities and differences suggest the need for tailored anti-stigma interventions. Curr. Res. Behav. Sci. 2025, 8, 100170. [Google Scholar] [CrossRef]
- Ono, I.; Nakatani, H.; Inoue, Y.; Peng, X.; Hamada, H. Development of the dementia attitude scale focusing on well-being. Front. Psychol. 2024, 15, 1410048. [Google Scholar] [CrossRef]
- Comas-Herrera, A.; International, A.D.; Aguzzoli, E.; Farina, N.; Read, S.; Evans-Lacko, S. World Alzheimer Report 2024: Global Changes in Attitudes to Dementia; Alzheimer’s Disease International: London, UK, 2024. [Google Scholar]
- Eckert, M.; Radhakrishnan, V.; Ostermann, T.; Ehlers, J.P.; Hohenberg, G. Virtual and Augmented Reality Games in Dementia Care: Systematic and Bibliographic Review. Healthcare 2025, 13, 2013. [Google Scholar] [CrossRef]
- Coutrot, A.; Schmidt, S.; Coutrot, L.; Pittman, J.; Hong, L.; Wiener, J.M.; Hölscher, C.; Dalton, R.C.; Hornberger, M.; Spiers, H.J. Virtual navigation tested on a mobile app is predictive of real-world wayfinding navigation performance. PLoS ONE 2019, 14, e0213272. [Google Scholar] [CrossRef]
- Spiers, H.J.; Coutrot, A.; Hornberger, M. Explaining World-Wide Variation in Navigation Ability from Millions of People: Citizen Science Project Sea Hero Quest. Top. Cogn. Sci. 2023, 15, 120–138. [Google Scholar] [CrossRef]
- Wang, J.; Shi, R.; Zheng, W.; Xie, W.; Kao, D.; Liang, H.N. Effect of Frame Rate on User Experience, Performance, and Simulator Sickness in Virtual Reality. IEEE Trans. Vis. Comput. Graph. 2023, 29, 2478–2488. [Google Scholar] [CrossRef] [PubMed]
- McNair, D.M.; Droppleman, L.F.; Lorr, M. Edits Manual for the Profile of Mood States: POMS; Educational and Industrial Testing Service: San Diego, CA, USA, 1992. [Google Scholar]
- Dalbert, C. ASTS—Aktuelle Stimmungsskala; Leibniz-Institut für Psychologie (ZPID) (Hrsg.); Open Test Archive: Trier, Germany, 2002. [Google Scholar] [CrossRef]
- Kourtesis, P.; Linnell, J.; Amir, R.; Argelaguet, F.; MacPherson, S.E. Cybersickness in Virtual Reality Questionnaire (CSQ-VR): A Validation and Comparison against SSQ and VRSQ. Virtual Worlds 2023, 2, 16–35. [Google Scholar] [CrossRef]
- Kourtesis, P.; Collina, S.; Doumas, L.A.A.; MacPherson, S.E. Validation of the Virtual Reality Neuroscience Questionnaire: Maximum Duration of Immersive Virtual Reality Sessions Without the Presence of Pertinent Adverse Symptomatology. Front. Hum. Neurosci. 2019, 13, 417. [Google Scholar] [CrossRef] [PubMed]
| Inclusion Criteria | Exclusion Criteria |
|---|---|
| Existing Diagnosis early ADRD (G30) | Diagnosed epilepsy (G.40) |
| Competence to consent | diagnosed anxiety disorders (F40–F41) |
| Impaired hearing (H90) | |
| Impaired vision (H54) | |
| Advanced dementia |
| Participant A | Participant B | Participant C | Mean ± SD | |
|---|---|---|---|---|
| Session duration (min) | 21 | 34 | 30 | 28.3 ± 6.7 |
| Session distance (km) | 0.2 | 1.1 | 1.3 | 0.9 ± 0.6 |
| Session steps | 588 | 1807 | 1236 | 1210 ± 610 |
| Participant A | Participant B | Participant C | Mean | |
|---|---|---|---|---|
| User Experience | 24 | 22 | 29 | 25.00 |
| Immersion | 4 | 3 | 5 | 4.00 |
| Pleasantness | 4 | 3 | 5 | 4.00 |
| Graphics | 6 | 6 | 7 | 6.33 |
| Sound | 6 | 4 | 5 | 5.00 |
| VR Tech | 4 | 6 | 7 | 5.67 |
| Game Mechanics | 20 | 25 | 18 | 21.00 |
| Orientation | 4 | 6 | 3 | 4.33 |
| Movement | 4 | 6 | 6 | 5.33 |
| Safety | 6 | 7 | 7 | 6.67 |
| Exploration | 6 | 6 | 2 | 5.67 |
| VRNQ-DE Score | 44 | 47 | 47 | 46.00 |
| VRNQ-DE Threshold | 45 | 45 | 45 | 45.00 |
| Participant A | Participant B | Participant C | |
|---|---|---|---|
| Trauer (Sadness) | 0 | 0 | 0 |
| Hoffnungslosigkeit (Hopelessness) | 0 | 0 | −1 |
| Müdigkeit (Fatigue) | 0 | −1 | +9 |
| Positive Stimmung (Positive Mood) | +3 | 0 | −9 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Eckert, M.; Ostermann, T.; Ehlers, J.P.; Hohenberg, G. Immersive, Open-World Virtual Reality for Dementia Care: NeuroVRX Pilot Study. J. Clin. Med. 2025, 14, 8465. https://doi.org/10.3390/jcm14238465
Eckert M, Ostermann T, Ehlers JP, Hohenberg G. Immersive, Open-World Virtual Reality for Dementia Care: NeuroVRX Pilot Study. Journal of Clinical Medicine. 2025; 14(23):8465. https://doi.org/10.3390/jcm14238465
Chicago/Turabian StyleEckert, Martin, Thomas Ostermann, Jan Peter Ehlers, and Gregor Hohenberg. 2025. "Immersive, Open-World Virtual Reality for Dementia Care: NeuroVRX Pilot Study" Journal of Clinical Medicine 14, no. 23: 8465. https://doi.org/10.3390/jcm14238465
APA StyleEckert, M., Ostermann, T., Ehlers, J. P., & Hohenberg, G. (2025). Immersive, Open-World Virtual Reality for Dementia Care: NeuroVRX Pilot Study. Journal of Clinical Medicine, 14(23), 8465. https://doi.org/10.3390/jcm14238465

